Creative Biostructure is a biotechnology company offering drug discovery contract services to pharma, biotech, chemical companies, and academic institutes. Based on our zebrafish screening platform, we can provide MagHelix™ toxicity assays using zebrafish. Zebrafish has been a prominent model vertebrate for investigating chemical toxicity.
Rapid access to detailed structural information about drug targets and bound ligands is significant in the identification and optimization of lead compounds. The structural information of the protein-ligand complex can accelerate the optimization process of potential lead compounds and help to solve problems related to compound selectivity, pharmacokinetics, as well as patentability.